Generating evidences on rational management of dermatophytic infections


  • Safi Abbas Rizvi Department of Dermatology and Cosmetic Medicine, Consultant Dermatologist, Dr Rizvi’s Multispecilaity Clinic, Lucknow, Uttar Pradesh, India
  • Som Lakhani Associate Professor, Department of Dermatology, PIMSR, Parul University, Vadodara, Gujarat, India



Dermatophytophytic infection, Corticosteroids, Therapeutic combinations, Antifungal agents


Superficial fungal infections are globally responsible for 25% of the skin mycoses cases. Dermatophytosis is a type of superficial fungal infection of skin, a significant cause of morbidity in the world. This pilot study includes most recent literatures with highest ratings and published work which has been submitted in last fifteen years. The literature review is completely oriented in reviewing evidence which includes the type of dermatophytic infection, diagnostic tools, therapeutic and non-therapeutic management of dermatophytic infection having highest level of evidences. Clinical diagnosis of dermatophytic infection and laboratory-based tests are vital in management of dermatophytic infections, considering conventional methods and incorporation of advanced techniques like preparation of skin specimens for microscopic examination by 10% to 20% mount microscopy, polymerase chain reaction, fungal culture, and spectroscopy. Over-use of corticosteroid is strictly discouraged as they carry multiple cutaneous adverse effects. A vast gap is evident in the management of dermatophytic infection with available reviews. Steroid abuse, in dermatophytic infection has led to many adverse effects and chronic skin conditions. Prevention and cure needs support of awareness about the disease and its severity.

Author Biography

Safi Abbas Rizvi, Department of Dermatology and Cosmetic Medicine, Consultant Dermatologist, Dr Rizvi’s Multispecilaity Clinic, Lucknow, Uttar Pradesh, India



Lakhani SJ, Shekhat P, Pandya I, Joshi H, Khadri H, Kapasiya R et al. Risk factors and the epidemiological profile of superficial fungal infections in patients of Waghodia Taluka of Vadodara District, India. J Dent Med Sci. 2016;15(12):23-6.

Zhan P, Liu W. The changing face of Dermatophytic infections worldwide. Mycopathologia. 2017;182(1-2):77-86.

Deshmukh SK. The occurrence of keratinophilic fungi in selected soils of Ladakh (India). Natural Sci. 2010;2:1247-52.

Ameen M. Epidemiology of superficial fungal infections. Clin Dermatol. 2010;28(2):197-201.

Araújo Gde M, Araújo ND, Farias RP, Cavalcanti FC, Lima Mdo L, Braz RA. Superficial mycoses in Paraíba: a comparative analysis and bibliographical revision. An Bras Dermatol. 2010;85:943-6.

Sahoo AK, Mahajan R. Management of tinea corporis, tinea cruris, and tinea pedis: A comprehensive review. Indian Dermatol Online J. 2016;7(2):77-86.

Adimi P, Hashemi SJ, Mahmoudi M, Mirhendi H, Shidfar MR, Emmami M. In-vitro Activity of 10 Antifungal Agents against 320 Dermatophyte Strains Using Microdilution Method in Tehran. Iran J Pharm Res. 2013;12(3):537-45.

Yadav A, Urhekar AD, Mane V, Danu MS, Goel N, Ajit KG. Optimization and isolation of dermatophytes from clinical samples and in vitro antifungal susceptibility testing by disc diffusion method. Res Rev. 2013;2(3):19-34.

Nweze EI. Dermatophytosis in Western Africa: a review. Pak J of Biol Sci. 2010;13:649-56.

Theel ES, Hall L, Mandrekar J, Wengenack NL. Dermatophyte identification using matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol. 2011;49(12):4067-71.

Rotta I, Ziegelmann PK, Otuki MF, Riveros BS, Bernardo NL, Correr CJ. Efficacy of topical antifungal in the treatment of dermatophytosis: a mixed treatment comparison meta-analysis involving 14 treatments. JAMA Dermatol. 2013;149(3):341-9.

Pathak A, Pandey H, Shukla SK, Kumar R, Pandey A, Dikshit A. Dermatophytosis: infection and prevention- a review. Int J Pharma Sci Res. 2016;7(7):2917-24.

Hey R. Therapy of Skin, Hair and Nail fungal infections. J Fungi (Basel). 2018;4(3):99.

Lakshmipathy DT, Kannabiran K. Review on Dermatomycosis: Pathogenesis and Treatment. Natural Sci. 2010;2(7):726-31.

Del Rosso JQ. Currrent managment of onychomycosis and dermatomycoses. Current Infectious Disease Reports. 2000;2(5):438-45.

Dogra S, Uprety S. The menace of chronic and recurrent dermatophytosis in India: is the problem deeper than we perceive? Indian Dermatol Online J. 2016;7:73-6.

Coondoo A, Phiske M, Verma S, Lahiri K. Indian Dermatol Online J; Side-effects of topical corticosteroids. A long overdue revisit. Indian Dermatol Online J. 2014;5:416-25.

Coondoo A, Chattopadhyay C. Use and abuse of topical corticosteroids in children. Indian J Paediatr Dermatol. 2014;15:1-4.

Verma S, Madhu R. The great Indian epidemic of superficial dermatophytosis: an appraisal. Indian J Dermatol. 2017;62(3):227-36.

Bhatia VK, Sharma PC. Epidemiological studies on Dermatophytosis in human patients in Himachal Pradesh, India. Springerplus. 2014;3:134.

Lakshmanan A, Ganeshkumar P, Mohan SR, Hemamalini M, Madhavan R. Epidemiological and clinical pattern of dermatomycoses in rural India. Indian J Med Microbiol. 2015;33:134-6.

Sharma Y, Jain S, Chandra K, Khurana VK, Kudesia M. Clinico-mycological evaluation of dermatophytes and non-dermatophytes isolated from various clinical samples: A study from north India. J Res Med Science. J Res Med Sci. 2012;17(8):817-8.






Review Articles